8-K//Current report
Y-mAbs Therapeutics, Inc. 8-K
Accession 0001558370-25-002174
CIK 0001722964operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:26 PM ET
Size
596.4 KB
Accession
0001558370-25-002174
Documents
- 8-Kymab-20250304x8k.htmPrimary
8-K
- EX-1.1ymab-20250304xex1d1.htm
EX-1.1
- EX-5.1ymab-20250304xex5d1.htm
EX-5.1
- GRAPHICymab-20250304xex5d1002.jpg
GRAPHIC
- EX-101.SCHymab-20250304.xsd
EX-101.SCH
- EX-101.LABymab-20250304_lab.xml
EX-101.LAB
- EX-101.PREymab-20250304_pre.xml
EX-101.PRE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001558370-25-002174-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLymab-20250304x8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001722964
Filing Metadata
- Form type
- 8-K
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:26 PM ET
- Size
- 596.4 KB